With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Filter the global stock universe by sector, market cap, P/E, ROE, dividend yield, and more. Covered tickers show our latest rating, fair value, and upside; data-only tickers still get profile, valuation, profitability, growth, ownership, and market indicators. For curated editorial screens (wide-moat, dividend aristocrats, etc.), see stock lists.
| Data only |
| CLOV | Clover Health Investments, Corp. Healthcare Plans | US / NASDAQ | Healthcare | USD 4.34 | 2.3B | n/a | -16.9% | +42.8% | Data only |
| COAG | Hemab Therapeutics Holdings, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 47.26 | 2.2B | n/a | n/a | n/a | Data only |
| HTFL | HeartFlow, Inc. Health Information Services | US / NASDAQ | Healthcare | USD 25.59 | 2.2B | n/a | -135.3% | n/a | Data only |
| AXGN | Axogen, Inc. Medical Devices | US / NASDAQ | Healthcare | USD 41.15 | 2.2B | n/a | -18.0% | +207.8% | Data only |
| ADUS | Addus HomeCare Corporation Medical Care Facilities | US / NASDAQ | Healthcare | USD 119 | 2.2B | 22.0x | +9.4% | +8.9% | Data only |
| AMLX | Amylyx Pharmaceuticals, Inc. Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | USD 19.55 | 2.2B | n/a | -63.3% | +139.9% | Data only |
| KLRA | Kailera Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 16.74 | 2.2B | n/a | n/a | n/a | Data only |
| VRDN | Viridian Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 19.51 | 2.2B | n/a | -58.1% | +12.9% | Data only |
| AVAH | Aveanna Healthcare Holdings Inc. Medical Care Facilities | US / NASDAQ | Healthcare | USD 9.89 | 2.2B | 8.3x | +368.0% | +149.7% | Data only |
| AGIO | Agios Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 35.99 | 2.1B | n/a | -32.8% | -10.0% | Data only |
| SION | Sionna Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 46.55 | 2.1B | n/a | -26.7% | +143.7% | Data only |
| IOVA | Iovance Biotherapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 4.70 | 2.1B | n/a | -47.5% | +50.2% | Data only |
| ZLAB | Zai Lab Limited Biotechnology | US / NASDAQ | Healthcare | USD 18.62 | 2.1B | n/a | -24.2% | -49.9% | Data only |
| HRMY | Harmony Biosciences Holdings, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 35.77 | 2.1B | 14.4x | +17.9% | -4.7% | Data only |
| PVLA | Palvella Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 143 | 2B | n/a | -34.2% | +269.9% | Data only |
| ZBIO | Zenas BioPharma, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 32.29 | 2B | n/a | -137.1% | +106.2% | Data only |
| ADMA | ADMA Biologics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 8.79 | 2B | 12.9x | +43.3% | -51.2% | Data only |
| ATRC | AtriCure, Inc. Medical Instruments & Supplies | US / NASDAQ | Healthcare | USD 39.75 | 2B | 188.5x | +2.2% | +26.2% | Data only |
| SGRY | Surgery Partners, Inc. Medical Care Facilities | US / NASDAQ | Healthcare | USD 15.58 | 2B | n/a | +2.7% | -26.7% | Data only |
| HCM | HUTCHMED (China) Limited Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | USD 11.20 | 2B | 4.4x | +45.3% | -36.4% | Data only |
| RAPP | Rapport Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 41.96 | 2B | n/a | -28.3% | +161.4% | Data only |
| NEOG | Neogen Corporation Medical Devices | US / NASDAQ | Healthcare | USD 9.19 | 2B | n/a | -25.6% | +76.1% | Data only |
| UFPT | UFP Technologies, Inc. Medical Devices | US / NASDAQ | Healthcare | USD 258 | 2B | 29.4x | +17.2% | +6.7% | Data only |
| URGN | UroGen Pharma Ltd. Biotechnology | US / NASDAQ | Healthcare | USD 40.88 | 2B | n/a | n/a | +115.7% | Data only |
| SLS | SELLAS Life Sciences Group, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 10.09 | 2B | n/a | -43.6% | +460.6% | Data only |
| PGEN | Precigen, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 5.53 | 2B | n/a | -1145.4% | +252.2% | Data only |
| FTRE | Fortrea Holdings Inc. Biotechnology | US / NASDAQ | Healthcare | USD 20.70 | 2B | n/a | -64.5% | +204.4% | Data only |
| OMCL | Omnicell, Inc. Health Information Services | US / NASDAQ | Healthcare | USD 43.05 | 2B | 97.8x | +1.6% | +52.3% | Data only |
| AUPH | Aurinia Pharmaceuticals Inc. Biotechnology | US / NASDAQ | Healthcare | USD 14.96 | 1.9B | 6.9x | +65.0% | +67.5% | Data only |
| GHRS | GH Research PLC Biotechnology | US / NASDAQ | Healthcare | USD 27.96 | 1.9B | n/a | -19.7% | +92.8% | Data only |
| NVCR | NovoCure Limited Medical Devices | US / NASDAQ | Healthcare | USD 16.31 | 1.9B | n/a | -43.2% | +35.5% | Data only |
| NBTX | Nanobiotix S.A. Biotechnology | US / NASDAQ | Healthcare | USD 37.82 | 1.9B | n/a | n/a | +455.4% | Data only |
| KARD | Kardigan, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 20.99 | 1.9B | n/a | n/a | n/a | Data only |
| FBRX | Forte Biosciences, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 76.65 | 1.9B | n/a | -188.4% | +560.8% | Data only |
| MESO | Mesoblast Limited Biotechnology | US / NASDAQ | Healthcare | USD 14.45 | 1.9B | n/a | -18.2% | -11.7% | Data only |
| GLUE | Monte Rosa Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 22.04 | 1.9B | n/a | -32.6% | +288.7% | Data only |
| LKFT | Lakefront Biotherapeutics NV Biotechnology | US / NASDAQ | Healthcare | USD 28.15 | 1.9B | 3.3x | +16.3% | -13.8% | Data only |
| OCUL | Ocular Therapeutix, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 8.45 | 1.9B | n/a | -68.6% | -30.8% | Data only |
| CDNA | CareDx, Inc. Diagnostics & Research | US / NASDAQ | Healthcare | USD 35.75 | 1.8B | n/a | -2.4% | +179.5% | Data only |
| WGS | GeneDx Holdings Corp. Diagnostics & Research | US / NASDAQ | Healthcare | USD 61.88 | 1.8B | n/a | -30.4% | -22.5% | Data only |
| TYRA | Tyra Biosciences, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 30.88 | 1.8B | n/a | -36.9% | +179.2% | Data only |
| STOK | Stoke Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 29.39 | 1.8B | n/a | -45.6% | +124.4% | Data only |
| DMRA | Damora Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 29.42 | 1.8B | n/a | -89.5% | +684.5% | Data only |
| MRVI | Maravai LifeSciences Holdings, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 6.86 | 1.8B | n/a | -41.0% | +155.0% | Data only |
| BCAX | Bicara Therapeutics Inc. Biotechnology | US / NASDAQ | Healthcare | USD 26.88 | 1.8B | n/a | -32.3% | +128.8% | Data only |
| TSHA | Taysha Gene Therapies, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 5.46 | 1.7B | n/a | -97.3% | +106.0% | Data only |
| NEO | NeoGenomics, Inc. Diagnostics & Research | US / NASDAQ | Healthcare | USD 13.40 | 1.7B | n/a | -6.3% | +113.0% | Data only |
| SNDX | Syndax Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 19.63 | 1.7B | n/a | -189.5% | +103.8% | Data only |
| ANIP | ANI Pharmaceuticals, Inc. Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | USD 81.04 | 1.7B | 20.8x | +18.3% | +20.1% | Data only |
